The Medical Society of Virginia believes that designating two separate and distinct billing processes for coverage of Long Acting Reversible Contraceptives (LARCs), is inefficient, confusing, and unnecessarily augmenting the administrative burden of providers seeking to administer care to Medicaid enrollees. Establishing different billing processes depending on the patient’s Medicaid coverage provider only piles on the administrative variations, similar to unique prior authorization practices, which providers must navigate in order to receive reimbursement for care provided to patients. MSV remains committed to continuing to work with regulatory and consumer stakeholders to reduce the administrative cost of providing care to Medicaid enrollees and improving the regulatory environment in order to further foster provider participation in Medicaid.